Searched for
GLENMARK PHARMA USFDA INDORE UNIT
Crofelemer approval by USFDA a big positive for co: GlenmarkGlenmark.jpg02 Jan, 2013, 11.47 AM IST- Glenmark Pharma under USFDA scanner21 Apr, 2016, 12.05 PM IST
- USFDA issues Form 483 to Glenmark's Indore plantGlenmark.jpg24 Dec, 2013, 12.40 PM IST
- USFDA to inspect Sun Pharma’s Halol unit04 Nov, 2016, 11.00 AM IST
- Watch: Aurobindo Pharma's Hyderabad unit gets 9 USFDA observations05 Mar, 2018, 03.16 PM IST
- Glenmark Pharma Q3 revenue rises 17 per centgp.jpg01 Feb, 2011, 04.42 PM IST
- Aurobindo Pharms's Hyderabad unit under USFDA lens20 Dec, 2016, 12.49 PM IST
- Aurobindo Pharms's Hyderabad unit under USFDA lens20 Dec, 2016, 12.48 PM IST
- Cipla at the bottom end of margin in industry: Umang Vohra02 Mar, 2017, 02.02 PM IST
- 2017 onward we are getting a lot of good news in pharma sector: Gurudatta GG15 Mar, 2017, 02.50 PM IST
- Stock Radar: Buy Glenmark Pharma for a target of Rs 474 in next 4-6 weeks, says Ajit Mishra16 Nov, 2022, 06.00 AM IST
- Lupin remains a top pick: Pankaj Pandey09 Feb, 2017, 02.08 PM IST
- USFDA bans Wockhardt unit08 Aug, 2016, 01.54 PM IST
- Glenmark Pharmaceuticals to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr21 Sep, 2023, 08.56 PM IST
- Napo termination unlikely to impact the company: GlenmarkGlenmark.jpg15 Dec, 2011, 11.55 AM IST
- Exclusive: Glenmark fund raising plansGlenmark.jpg27 Aug, 2009, 03.25 PM IST
- Glenmark, Sanofi in license pact for Crohn's disease drugPharma-5.jpg16 May, 2011, 09.39 AM IST
- Watch: Lupin gets USFDA warning for Indore, Goa facilities07 Nov, 2017, 03.43 PM IST
- Exclusive: USFDA's letter to Sun Pharma's Halol plant13 Dec, 2016, 04.38 PM IST
- Dr Reddy's gains after FDA blow to Ranbaxy07 Nov, 2014, 03.07 PM IST
Load More
